What this means
This review looked at lab, animal, and human studies of epitalon. It says the peptide is biologically active but not yet proven to help people.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- A review of studies in cells, animals, and people
- Kind of research
- A summary of earlier studies
The science
- Original title
- Epitalon and Epithalamin: A Narrative Review of Mechanistic, Preclinical, and Clinical Evidence.
- Authors
- Jain A, Gallacher DM, Issa MA et al.
- Journal
- International journal of molecular sciences
- Published
- Oct 16, 2026
- Study type
- Review · in humans
- PMID
- 42884164 ↗
Abstract
Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide developed from the amino-acid composition of epithalamin, a chemically distinct pineal-derived polypeptide preparation. This narrative review evaluates the mechanistic, preclinical, and human evidence for synthetic epitalon in the context of regenerative and longevity medicine, while considering epithalamin studies separately as historical context. PubMed and Google Scholar were searched through 22 September 2026, with primary experimental and clinical studies prioritized and evidence appraised by study design, model, sample size, intervention, outcomes, safety reporting, and independent replication. Epitalon has been reported to modulate telomere-maintenance pathways, circadian and neuroendocrine function, oxidative stress, and cellular aging markers. Preclinical studies suggest biological activity, but direct evidence in musculoskeletal disease models is lacking. Human evidence is limited to small physiological or biomarker studies and an older controlled study in retinitis pigmentosa; no adequately powered randomized trial has established therapeutic efficacy. Pharmacokinetic, dose-ranging, and long-term safety data remain inadequate, while oncologic, immunogenicity, product-quality, and regulatory uncertainties following a 2026 FDA advisory review remain unresolved. Epitalon is therefore biologically active but clinically unproven, and further standardized pharmacologic, safety, and disease-specific studies are needed before clinical translation.
Jain A, Gallacher DM, Issa MA et al. Epitalon and Epithalamin: A Narrative Review of Mechanistic, Preclinical, and Clinical Evidence. International journal of molecular sciences. 2026. doi:10.3390/ijms27198922. PMID: 42884164. https://pubmed.ncbi.nlm.nih.gov/42884164/